# ABCA3

## Overview
The ABCA3 gene encodes the ATP-binding cassette subfamily A member 3 (ABCA3) protein, which is a critical component of the ATP-binding cassette (ABC) transporter family. This protein is primarily involved in the transport of lipids across cellular membranes, particularly within the alveolar type II cells of the lungs. ABCA3 plays a vital role in the formation and function of lamellar bodies, which are essential for the storage and secretion of pulmonary surfactant, a substance crucial for reducing surface tension in the alveoli and facilitating efficient gas exchange (Beers2016The; Mulugeta2002Identification). As a transmembrane protein, ABCA3 is integral to maintaining surfactant homeostasis and cholesterol balance within cells. Mutations in the ABCA3 gene can lead to significant pulmonary disorders, highlighting its importance in respiratory health (Beers2016The; Zarbock2015ABCA3).

## Structure
The ABCA3 protein is a member of the ATP-binding cassette (ABC) transporter family, specifically the A-subfamily, and is encoded by the ABCA3 gene located on human chromosome 16. It is composed of 1704 amino acids and has a molecular weight of approximately 191.39 kDa (Paolini2015Structural; Kaminski2006ABC). Structurally, ABCA3 is organized into two tandem functional units, each consisting of a transmembrane domain (TMD) and a nucleotide-binding domain (NBD). The TMDs are formed by six hydrophobic membrane-spanning α-helices, with the N-half and C-half connected by loops of varying lengths (Paolini2015Structural; Kaminski2006ABC). The NBDs contain seven motifs, including the Walker A and B motifs, which are crucial for ATP binding and hydrolysis (Paolini2015Structural).

The protein's secondary structure shows similarity with NBDs of other species, indicating conserved features across different organisms (Paolini2015Structural). Although the exact 3D crystal structure is not available, homology modeling suggests that the NBDs of ABCA3 have a structural organization similar to other ABC transporters (Paolini2015Structural). The lack of a crystal structure makes it challenging to determine the precise localization and functional roles of the domains (Paolini2015Structural). ABCA3 is predominantly expressed in alveolar type II cells in the lung, where it is concentrated in the membrane of lamellar bodies, playing a crucial role in surfactant metabolism (Albrecht2006The; Kaminski2006ABC).

## Function
The ABCA3 gene encodes a protein that is a member of the ATP-binding cassette (ABC) transporter family, specifically involved in lipid transport across cellular membranes. In healthy human cells, particularly in alveolar type II (ATII) cells of the lungs, ABCA3 plays a crucial role in the formation and function of lamellar bodies, which are organelles responsible for storing and secreting pulmonary surfactant. This surfactant is essential for reducing surface tension in the alveoli, preventing their collapse, and facilitating efficient gas exchange (Beers2016The; Mulugeta2002Identification).

ABCA3 is localized to the limiting membrane of lamellar bodies, where it transports phospholipids and cholesterol into these organelles. This transport is vital for the biogenesis of lamellar bodies and the maintenance of surfactant homeostasis (Yamano2001ABCA3; Zarbock2015ABCA3). The protein is involved in the regulation of several lipids, including phosphatidylcholine and phosphatidylglycerol, which are the most abundant phospholipids in surfactant (Beers2016The).

Mutations in the ABCA3 gene can disrupt these processes, leading to impaired surfactant production and associated pulmonary diseases (Beers2016The). The protein's function is also linked to cholesterol homeostasis, as it acts as a free cholesterol exporter, helping to maintain cellular cholesterol balance and protect against cholesterol-induced cell damage (Zarbock2015ABCA3).

## Clinical Significance
Mutations in the ABCA3 gene are linked to a variety of pulmonary disorders due to their critical role in surfactant homeostasis. Over 200 distinct mutations have been identified, making ABCA3 mutations the most prevalent in surfactant-related lung disorders. These mutations can lead to severe neonatal lung disease, often resulting in early death, with histopathological features such as pulmonary fibrosis, alveolar type II (AT2) cell hyperplasia, and airspace infiltration by foamy macrophages. Conditions associated with these mutations include chronic pneumonitis of infancy (CPI), nonspecific interstitial pneumonia (NSIP), neonatal or congenital pulmonary alveolar proteinosis (PAP), and infantile desquamative interstitial pneumonia (DIP) (Beers2016The).

Some ABCA3 mutations result in chronic phenotypes affecting older children and adults, leading to conditions such as childhood interstitial lung disease (chILD), idiopathic pulmonary fibrosis (IPF), or diffuse parenchymal lung disease (DPLD) (Beers2016The). The mutations can cause partial loss-of-function or toxic gain-of-function phenotypes, with in vitro studies classifying them into three types: Type I mutations cause protein misfolding and ER stress, Type II mutations affect ATP hydrolysis and lipid transfer, and Type III mutations are compound heterozygotes with severe phenotypes (Beers2016The). The most common mutation, E292V, is a Type II mutation associated with IPF/DPLD phenotypes (Beers2016The).

## Interactions
ABCA3 is primarily involved in lipid transport and surfactant metabolism in alveolar type II cells. While specific physical interactions of ABCA3 with other proteins or nucleic acids are not extensively detailed, its role in surfactant biogenesis suggests interactions with surfactant proteins. Within lamellar bodies, ABCA3 exports lipids that interact with surfactant proteins SP-B and SP-C to form pulmonary surfactant, indicating a functional association rather than direct physical binding (Paolini2015Structural).

ABCA3 is also associated with cholesterol transport within late endosomal compartments. It colocalizes with the cholesterol-binding protein MLN64 in MLN64-positive vesicles, which are involved in the early stages of cholesterol processing. This suggests a compartmental interaction in cholesterol trafficking, although direct physical interactions are not specified (van2013Cholesterolbinding).

The protein's oligomerization is crucial for its function, as demonstrated by its ability to form dimers and possibly higher-order oligomers. This self-association is essential for its lipid transport activity, and mutations that disrupt oligomerization, such as the p.Q215K mutation, can impair its function (Frixel2016Homooligomerization). However, specific interactions with other proteins or nucleic acids are not detailed in the context provided.


## References


[1. (Paolini2015Structural) Alessandro Paolini, Antonella Baldassarre, Ilaria Del Gaudio, and Andrea Masotti. Structural features of the atp-binding cassette (abc) transporter abca3. International Journal of Molecular Sciences, 16(8):19631–19644, August 2015. URL: http://dx.doi.org/10.3390/ijms160819631, doi:10.3390/ijms160819631. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms160819631)

[2. (Beers2016The) Michael F. Beers and Surafel Mulugeta. The biology of the abca3 lipid transporter in lung health and disease. Cell and Tissue Research, 367(3):481–493, December 2016. URL: http://dx.doi.org/10.1007/s00441-016-2554-z, doi:10.1007/s00441-016-2554-z. This article has 80 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00441-016-2554-z)

[3. (Yamano2001ABCA3) Gen Yamano, Hisayuki Funahashi, Oichi Kawanami, Li-Xia Zhao, Nobuhiro Ban, Yoshiyuki Uchida, Toshio Morohoshi, Junichi Ogawa, Seiji Shioda, and Nobuya Inagaki. Abca3 is a lamellar body membrane protein in human lung alveolar type ii cells1. FEBS Letters, 508(2):221–225, October 2001. URL: http://dx.doi.org/10.1016/s0014-5793(01)03056-3, doi:10.1016/s0014-5793(01)03056-3. This article has 215 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0014-5793(01)03056-3)

[4. (Kaminski2006ABC) Wolfgang E. Kaminski, Armin Piehler, and Jürgen J. Wenzel. Abc a-subfamily transporters: structure, function and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1762(5):510–524, May 2006. URL: http://dx.doi.org/10.1016/j.bbadis.2006.01.011, doi:10.1016/j.bbadis.2006.01.011. This article has 147 citations.](https://doi.org/10.1016/j.bbadis.2006.01.011)

[5. (Albrecht2006The) Christiane Albrecht and Enrique Viturro. The abca subfamily—gene and protein structures, functions and associated hereditary diseases. Pflügers Archiv - European Journal of Physiology, 453(5):581–589, April 2006. URL: http://dx.doi.org/10.1007/s00424-006-0047-8, doi:10.1007/s00424-006-0047-8. This article has 88 citations.](https://doi.org/10.1007/s00424-006-0047-8)

[6. (Mulugeta2002Identification) Surafel Mulugeta, Joseph M. Gray, Kathleen L. Notarfrancesco, Linda W. Gonzales, Michael Koval, Sheldon I. Feinstein, Philip L. Ballard, Aron B. Fisher, and Henry Shuman. Identification of lbm180, a lamellar body limiting membrane protein of alveolar type ii cells, as the abc transporter protein abca3. Journal of Biological Chemistry, 277(25):22147–22155, June 2002. URL: http://dx.doi.org/10.1074/JBC.M201812200, doi:10.1074/jbc.m201812200. This article has 252 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M201812200)

[7. (Frixel2016Homooligomerization) Sabrina Frixel, Amelie S. Lotz-Havla, Sunčana Kern, Eva Kaltenborn, Thomas Wittmann, Søren W. Gersting, Ania C. Muntau, Ralf Zarbock, and Matthias Griese. Homooligomerization of abca3 and its functional significance. International Journal of Molecular Medicine, 38(2):558–566, June 2016. URL: http://dx.doi.org/10.3892/ijmm.2016.2650, doi:10.3892/ijmm.2016.2650. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijmm.2016.2650)

[8. (Zarbock2015ABCA3) Ralf Zarbock, Eva Kaltenborn, Sabrina Frixel, Thomas Wittmann, Gerhard Liebisch, Gerd Schmitz, and Matthias Griese. Abca3 protects alveolar epithelial cells against free cholesterol induced cell death. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1851(7):987–995, July 2015. URL: http://dx.doi.org/10.1016/j.bbalip.2015.03.004, doi:10.1016/j.bbalip.2015.03.004. This article has 19 citations.](https://doi.org/10.1016/j.bbalip.2015.03.004)

[9. (van2013Cholesterolbinding) Rik van der Kant, Ilse Zondervan, Lennert Janssen, and Jacques Neefjes. Cholesterol-binding molecules mln64 and orp1l mark distinct late endosomes with transporters abca3 and npc1. Journal of Lipid Research, 54(8):2153–2165, August 2013. URL: http://dx.doi.org/10.1194/jlr.m037325, doi:10.1194/jlr.m037325. This article has 86 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.m037325)